Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma
Hector H. Huang, Ian Ferguson, Alexis M. Thornton, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Alternative splicing and cancer: a systematic review
Yuanjiao Zhang, Jinjun Qian, Chunyan Gu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 307
Protein kinase R is an innate immune sensor of proteotoxic stress via accumulation of cytoplasmic IL-24
Sophia Davidson, Chien‐Hsiung Yu, Annemarie Steiner, et al.
Science Immunology (2022) Vol. 7, Iss. 68
Open Access | Times Cited: 46
Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma
Klara Kropivšek, Paul Kachel, Sandra Goetze, et al.
Nature Cancer (2023) Vol. 4, Iss. 5, pp. 734-753
Open Access | Times Cited: 26
Neoantigens in cancer immunotherapy: focusing on alternative splicing
Peng Huang, Feng Wen, Nuerye Tuerhong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Non-canonical functions of spliceosome components in cancer progression
O.M. Ivanova, Ksenia S. Anufrieva, Anastasia N. Kazakova, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 21
Proteomic characterization of post-translational modifications in drug discovery
Linhui Zhai, Kai‐Feng Chen, Bingbing Hao, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 12, pp. 3112-3129
Open Access | Times Cited: 23
A neutrophil extracellular trap-related risk score predicts prognosis and characterizes the tumor microenvironment in multiple myeloma
Zhijia Zhao, Yuan Huo, Yufeng Du, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Bone Marrow Stroma-Induced Transcriptome and Regulome Signatures of Multiple Myeloma
Sebastian A. Dziadowicz, Lei Wang, Halima Akhter, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 927-927
Open Access | Times Cited: 20
Chronic Exposure to Low Levels of Parabens Increases Mammary Cancer Growth and Metastasis in Mice
Jason H. Tong, Sarah E. Elmore, Shenq‐Shyang Huang, et al.
Endocrinology (2023) Vol. 164, Iss. 3
Open Access | Times Cited: 12
Overcoming proteasome inhibitor resistance in the immunotherapy era
Bonell Patiño-Escobar, Alexis Talbot, Arun P. Wiita
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 8, pp. 507-518
Open Access | Times Cited: 12
Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma
Ian Ferguson, Yu-Hsiu T. Lin, Christine Lam, et al.
Cell chemical biology (2022) Vol. 29, Iss. 8, pp. 1288-1302.e7
Open Access | Times Cited: 18
Targeting CLK4 inhibits the metastasis and progression of breast cancer by inactivating TGF-β pathway
Eunji Kang, SangWoo Kim, Sook Young Jeon, et al.
Cancer Gene Therapy (2022) Vol. 29, Iss. 8-9, pp. 1168-1180
Closed Access | Times Cited: 15
Differential RNA splicing as a potentially important driver mechanism in multiple myeloma
Michael Bauer, Cody Ashby, Christopher P. Wardell, et al.
Haematologica (2020) Vol. 106, Iss. 3, pp. 736-745
Open Access | Times Cited: 22
Identification and Validation of a Novel RNA-Binding Protein-Related Gene-Based Prognostic Model for Multiple Myeloma
Wei Wang, Shiwen Xu, Xia-yin Zhu, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 19
AATF/Che‐1 localizes to paraspeckles and suppresses R‐loops accumulation and interferon activation in Multiple Myeloma
Tiziana Bruno, Giacomo Corleone, Valeria Catena, et al.
The EMBO Journal (2022) Vol. 41, Iss. 22
Open Access | Times Cited: 14
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors
Anıl Aktaş Samur, Mariateresa Fulciniti, Hervé Avet‐Loiseau, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 12
Open Access | Times Cited: 14
Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma
Sophia Adamia, Shruti Bhatt, Kenneth Wen, et al.
Leukemia (2022) Vol. 36, Iss. 4, pp. 1088-1101
Open Access | Times Cited: 13
Collateral deletion of the mitochondrial AAA+ ATPase ATAD1 sensitizes cancer cells to proteasome dysfunction
Jacob M. Winter, Heidi L. Fresenius, Corey N. Cunningham, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 13
Broad variation in response of individual introns to splicing inhibitors in a humanized yeast strain
Oarteze Hunter, Jason Talkish, Jen Quick-Cleveland, et al.
RNA (2023) Vol. 30, Iss. 2, pp. 149-170
Open Access | Times Cited: 7
PRRGO: A Tool for Visualizing and Mapping Globally Expressed Genes in Public Gene Expression Omnibus RNA-Sequencing Studies to PageRank-scored Gene Ontology Terms
Luis E. Solano, Nicholas M. D’Sa, Nikolas Nikolaidis
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Nicotinamide Mononucleotide (NMN) Works in Type 2 Diabetes through Unexpected Effects in Adipose Tissue, Not by Mitochondrial Biogenesis
Roua Gabriela Popescu, Anca Dinischiotu, T. Soare, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2594-2594
Open Access | Times Cited: 2
Splicing dysregulation in human hematologic malignancies: beyond splicing mutations
Jonas De Kesel, Igor Fijałkowski, Justin Taylor, et al.
Trends in Immunology (2022) Vol. 43, Iss. 8, pp. 674-686
Open Access | Times Cited: 11
LMNB2 is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
Weihao Kong, Zihao Wu, Mingwei Yang, et al.
IUBMB Life (2020) Vol. 72, Iss. 12, pp. 2672-2685
Open Access | Times Cited: 15
Pathogenic signaling in multiple myeloma
Arnold Bolomsky, Ryan M. Young
Seminars in Oncology (2022) Vol. 49, Iss. 1, pp. 27-40
Open Access | Times Cited: 9
Proteomic analysis of human iPSC-derived sensory neurons implicates cell stress and microtubule dynamics dysfunction in bortezomib-induced peripheral neurotoxicity
Sybil C. L. Hrstka, Soneela Ankam, Busranur Agac, et al.
Experimental Neurology (2020) Vol. 335, pp. 113520-113520
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top